# What TRT Ad Creative Passes Meta and Google Review?

Reviewed October 6, 2026 · By Michael Borgia, MedScale Health

## Short answer

As of October 2026, TRT creative passes review when it sells the clinic rather than the hormone: a clinician on camera, the steps of the process, a clear price for the visit and labs, and a consultation as the first step. Body before-and-after, second-person "low T" lines and naming testosterone without LegitScript and platform authorization are what fail. MedScale Health, a paid acquisition agency for telehealth brands and clinics, builds TRT creative on these four formats.

## What this means for you

- Lead with a person: a clinician or the founder explaining the process, filmed simply.
- Show the steps: labs, a visit with a licensed clinician, and a plan if treatment is appropriate.
- Price the visit and the labs, never the medication, until you are authorized.
- Make a consultation the first step, and end every video on that offer.
- Leave out body transformations, second-person "low T" lines and drug names until LegitScript certification and each platform's authorization are in place.

MedScale Health, a paid acquisition agency for telehealth brands and clinics, builds creative for men's health and TRT brands. The guidance below combines the platform rules, checked on their primary pages, with what MedScale has seen in its own review of client ad accounts. Those observations are qualitative and come from a small number of accounts. They are not benchmarks. This page is marketing guidance, not medical or legal advice. Platform policies change, so check the sources listed at the end before acting on a specific rule.

## Four formats that run

Clinician-led video. A licensed clinician or the founder talks to camera about who the program is for, what the first visit involves and what happens next. Plain phone-filmed video of a real clinician or staff member is enough; polish matters less than a clear, factual message. Nothing in the format asserts anything about the viewer, which is why it clears review.

Process explainers. Three or four steps on screen: book, labs, visit, plan. Static cards and short motion both work. The ad describes the service, and the clinical detail lives on the landing page.

Price transparency. A clear price for the consultation or the lab panel tells people what the first step costs. Price the visit, not the drug. A dollar figure next to a medication reads as an offer to sell a prescription drug, which puts the ad under prescription drug rules on both platforms.

Consult first. The call to action is a consultation or a lab test, with medication only if the clinician decides it is appropriate. End every video on that offer. A video that ends without a clear next step leaves the viewer with nothing to do.

## What fails

- Body before-and-after. Meta's July 22, 2026 change lets 18+ ads for cosmetic products and procedures show before-and-after, and lets 18+ dietary weight loss ads show people using the product and its impact. Testosterone therapy is not one of those categories, and Meta sends prescription treatments to its Drugs and Pharmaceuticals policy. A body transformation also reads as a typical result: the FTC's endorsement guides say a consumer's results are likely to be read as what others will generally achieve. MedScale's own rule is stricter still: no before-and-after in any ad we run.
- Second-person "low T" lines. "Your low T is holding you back" or "Tired and foggy? It could be your testosterone" assert a health attribute about the viewer, which Meta's personal attributes policy bars. "Testosterone testing and care for men, led by licensed clinicians" describes the service instead.
- Drug names without authorization. On Meta, ads that promote prescription drugs need active LegitScript certification, Meta's authorization, 18+ targeting and an eligible country. On Google in the US, any advertiser may name a prescription drug in ads and on landing pages, but keyword-targeting it needs certification, and telemedicine providers need certification before prescription drug service ads serve.
- Outcome promises. "More energy in two weeks" promises a specific outcome in a set timeframe, which Meta bars in a health context without qualifiers, and Google rejects improbable results presented as the likely outcome.
- Approval claims for compounded products. If a product is compounded, it is compounded, not FDA-approved, and copy should never suggest it is the same as a branded drug.

Some formats did poorly in our review even where policy allowed them: grievance hooks, comparison tables, blog-style advertorials, videos that open on the disclaimer, and mood with no offer. Lead with the answer and the first step instead.

## How the formats work as a set

No single format carries an account. We build each campaign as a set of 5 to 7 ads: clinician-led video, a process card, a price-led static and one or two founder or creator videos, all on the same offer. Each week the weakest ads are switched off. Each month the set gets a new round, including new versions of last month's winners, so a winning static becomes a motion video and the reverse. The client approves each round in one pass.

## What MedScale does

MedScale Health builds TRT creative in sets, each ad pre-checked against Meta's and Google's health rules, with landing pages that carry the clinical detail and the prescription-required wording. Drug-named campaigns wait for LegitScript and each platform's authorization, which MedScale's certification help can file alongside the ads that can run now. MedScale tracks server-side under a BAA with neutral event names, and no names, emails, phone numbers, IP addresses or browser IDs go to any ad platform. No approval or result is promised. Book the free growth audit at medscale.health/audit.

## FAQ

**Can TRT ads use before-and-after photos on Meta?**

Meta's July 2026 change allows before-and-after in 18+ ads for cosmetic products and procedures and lets 18+ dietary weight loss ads show impact. Testosterone therapy isn't one of those categories, and MedScale runs no before-and-after in any ad as a house rule.

**Can a TRT ad say low T?**

Not about the viewer. "Low T?" or "your low testosterone" asserts a health attribute, which Meta's personal attributes policy bars. Naming the service is fine: "Testosterone testing and care for men" describes what you offer, not the person reading.

**Can we name testosterone in TRT ads?**

On Meta, only with active LegitScript certification and Meta's authorization, targeting 18+ in eligible countries. On Google in the US, naming it in ad text needs no certification, but keyword-targeting it does, and a telemedicine provider needs certification for prescription drug ads to serve.

**What TRT ad format works best?**

No format is guaranteed. Clinician-led video filmed simply, process explainers and clear first-step prices are the formats that fit the rules best, while grievance hooks, advertorials and mood without an offer give a reviewer and a viewer little to work with. Test several formats as one set.

**Can we show the price of TRT in ads?**

Show the price of the visit or the lab panel, not the medication. A dollar figure next to a drug reads as prescription drug promotion, which on Meta needs LegitScript certification and authorization first. List the consultation price and say medication is priced separately if prescribed.

## Sources

- [Meta Advertising Standards: Drugs and Pharmaceuticals](https://transparency.meta.com/policies/ad-standards/restricted-goods-services/drugs-pharmaceuticals/) (checked October 5, 2026)
- [Meta Advertising Standards: Health and Wellness (updated Jul 22, 2026)](https://transparency.meta.com/policies/ad-standards/restricted-goods-services/health-wellness/) (checked October 5, 2026)
- [Meta Advertising Standards: Privacy Violations and Personal Attributes](https://transparency.meta.com/policies/ad-standards/objectionable-content/privacy-violations-personal-attributes/) (checked October 5, 2026)
- [Google Ads policy: Restricted drug terms](https://support.google.com/adspolicy/answer/15595717?hl=en) (checked October 5, 2026)
- [Google Ads policy: Prescription drug services](https://support.google.com/adspolicy/answer/15598647?hl=en) (checked October 5, 2026)
- [Google Ads policy: Misrepresentation (unreliable claims)](https://support.google.com/adspolicy/answer/6020955?hl=en) (checked October 5, 2026)
- [FTC Endorsement Guides, 16 CFR 255.2: consumer endorsements (eCFR)](https://www.ecfr.gov/current/title-16/chapter-I/subchapter-B/part-255/section-255.2) (checked October 5, 2026)

## Related

- [Can You Advertise TRT on Meta?](https://medscale.health/answers/can-you-advertise-trt-on-meta)
- [How Do You Advertise TRT on Meta and Google Without Losing the Account?](https://medscale.health/answers/how-to-advertise-trt-on-meta-and-google)
- [What Does GLP-1 Ad Creative That Survives Review Look Like?](https://medscale.health/answers/glp-1-ad-creative-that-survives-review)
- [What Makes a Telehealth Landing Page Pass Meta and Google Review?](https://medscale.health/answers/telehealth-landing-page-compliance)

Canonical page: https://medscale.health/answers/trt-ad-creative-that-passes-review